跳至主要内容
临床试验/NCT05783141
NCT05783141招募中不适用

Double-blind, Randomized Placebo-controlled Trial Investigating Cumulative or Even Synergistic Effects of a Novel Prebiotic Combination in Healthy Toddlers

Beneo-Institute2 个研究点 分布在 1 个国家目标入组 342 人开始时间: 2023年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
342
试验地点
2
主要终点
Absenteeism

研究概览

简要总结

The aim of this study is to demonstrate that a dietary supplementation with a novel prebiotic combination is safe, well tolerated and able to improve overall health of toddlers.

详细描述

The fermentation of a novel prebiotic combination leads to a modulation of the gut microbiota composition, in particular to a growth stimulation of bifidobacteria, and the production of organic acids like lactate and short-chain fatty acids (SCFA).The efficacy of the prebiotic combination to improve toddler's digestive function will be addressed. The overall health will be assessed as a measure of reduced number of febrile days resulting in less days of absenteeism from daycare centers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
10 Months 至 36 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Child is healthy at the time of pre-examination
  • Child is aged between 10-36 months and attends a day care center for the duration of the intervention
  • Child attends a daycare center at the time of pre examination for at least 50%.
  • Child presents a normal defecation characteristic (according to Brussels Infant and Toddler Stool scale)
  • Weight for height z-score >-2 and <2 SD based on Flemish growth charts
  • Child and legal guardian are able and willing to follow the study instructions
  • Child is suitable for participation in the study according to the investigator/ study personnel
  • Informed written consent given by parent / legal guardian

排除标准

  • No legal guardian's command of any local language
  • Child with any chronic disorder or disease, e.g., defecation disorders (incl. Hirschsprung and celiac disease) metabolic or renal abnormalities as well as mental or psychomotor retardation (incl. child´s mental delay and hypotonia)
  • Child is suffering from congenital or acquired immunodeficiency
  • Food allergies or intolerances
  • Child is currently breast-fed more than once daily
  • Use of drugs (e.g. antibiotics) influencing gastrointestinal function (6 weeks before intervention)
  • Use of laxatives (4 weeks before intervention) as well as probiotic and prebiotic food supplements. Follow-on formula with L. Reuteri and/or GOS/FOS/HMO is allowed.
  • Child is suffering from an infection at the time of pre examination or previous 7 days
  • Child is currently involved or will be involved in another clinical or food study
  • Child is not suitable for participation in the study according to the study personnel´s opinion

结局指标

主要结局

Absenteeism

时间窗: Data collected continuously from enrollment until end of intervention (up to 90 days).

Number of days of child´s absence from day care center due to infectious episodes or antibiotic treatment.

Fever

时间窗: Data collected continuously from enrollment until end of intervention (up to 90 days).

Number of febrile days (peak temperature of forehead at least 38.0°C)

次要结局

  • Stool frequency(Data collected continuously from enrollment until end of intervention (up to 90 days).)
  • Stool consistency(Data collected continuously from enrollment until end of intervention (up to 90 days).)
  • Beneficial colonization(Stool sample collected at baseline and after 90 days intervention period)
  • Caretaker´s absenteeism from work(Data collected continuously from enrollment until end of intervention (up to 90 days).)

研究者

发起方
Beneo-Institute
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Prebiotic Effects in Healthy Toddlers | 临床试验